日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium difficile Cytidylate kinase (cmk) CSB-YP618237CAAQ
CSB-EP618237CAAQ
CSB-BP618237CAAQ
CSB-MP618237CAAQ
CSB-EP618237CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile LexA repressor (lexA) CSB-YP618238CAAQ
CSB-EP618238CAAQ
CSB-BP618238CAAQ
CSB-MP618238CAAQ
CSB-EP618238CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable ATP synthase subunit g 2, mitochondrial (asg-2) CSB-YP618239CXY
CSB-EP618239CXY
CSB-BP618239CXY
CSB-MP618239CXY
CSB-EP618239CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Acetylglutamate kinase (argB) CSB-YP618240CAAQ
CSB-EP618240CAAQ
CSB-BP618240CAAQ
CSB-MP618240CAAQ
CSB-EP618240CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eukaryotic translation initiation factor 3 subunit F (eif-3.F) CSB-YP618241CXY
CSB-EP618241CXY
CSB-BP618241CXY
CSB-MP618241CXY
CSB-EP618241CXY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Glycine cleavage system H protein (gcvH) CSB-YP618242CAAQ
CSB-EP618242CAAQ
CSB-BP618242CAAQ
CSB-MP618242CAAQ
CSB-EP618242CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile UPF0371 protein CD630_08980 (CD630_08980), partial CSB-YP618243CAAQ
CSB-EP618243CAAQ
CSB-BP618243CAAQ
CSB-MP618243CAAQ
CSB-EP618243CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Acetyl-CoA acetyltransferase (thlA) CSB-YP618244CAAQ
CSB-EP618244CAAQ
CSB-BP618244CAAQ
CSB-MP618244CAAQ
CSB-EP618244CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L27 (rpmA) CSB-YP618245CAAQ
CSB-EP618245CAAQ
CSB-BP618245CAAQ
CSB-MP618245CAAQ
CSB-EP618245CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Fructose-1,6-bisphosphatase class 3 (fbp), partial CSB-YP618246CAAQ
CSB-EP618246CAAQ
CSB-BP618246CAAQ
CSB-MP618246CAAQ
CSB-EP618246CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Ribosome maturation factor RimM (rimM) CSB-YP618247CAAQ
CSB-EP618247CAAQ
CSB-BP618247CAAQ
CSB-MP618247CAAQ
CSB-EP618247CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile UPF0297 protein CD630_12830 (CD630_12830) CSB-YP618248CAAQ
CSB-EP618248CAAQ
CSB-BP618248CAAQ
CSB-MP618248CAAQ
CSB-EP618248CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Ribosome-binding factor A (rbfA) CSB-YP618249CAAQ
CSB-EP618249CAAQ
CSB-BP618249CAAQ
CSB-MP618249CAAQ
CSB-EP618249CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Ribonuclease Y (rny), partial CSB-YP618250CAAQ
CSB-EP618250CAAQ
CSB-BP618250CAAQ
CSB-MP618250CAAQ
CSB-EP618250CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Deoxyribose-phosphate aldolase (deoC) CSB-YP618251CAAQ
CSB-EP618251CAAQ
CSB-BP618251CAAQ
CSB-MP618251CAAQ
CSB-EP618251CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile UPF0133 protein CD630_00170 (CD630_00170) CSB-YP618252CAAQ
CSB-EP618252CAAQ
CSB-BP618252CAAQ
CSB-MP618252CAAQ
CSB-EP618252CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile Proline--tRNA ligase 2 (proS2) CSB-YP618253CAAQ
CSB-EP618253CAAQ
CSB-BP618253CAAQ
CSB-MP618253CAAQ
CSB-EP618253CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile DNA-directed RNA polymerase subunit beta (rpoB), partial CSB-YP618254CAAQ
CSB-EP618254CAAQ
CSB-BP618254CAAQ
CSB-MP618254CAAQ
CSB-EP618254CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 50S ribosomal protein L23 (rplW) CSB-YP618255CAAQ
CSB-EP618255CAAQ
CSB-BP618255CAAQ
CSB-MP618255CAAQ
CSB-EP618255CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium difficile 30S ribosomal protein S3 (rpsC) CSB-YP618256CAAQ
CSB-EP618256CAAQ
CSB-BP618256CAAQ
CSB-MP618256CAAQ
CSB-EP618256CAAQ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×